-
DO NOT USE - Whole genome sequencing of SI-NETs from five patients
Study
EGAS00001004435
-
DO NOT USE - Whole genome sequencing of SI-NETs from six patients
Study
EGAS00001005009
-
Chromatin accessibility of clear cell renal cell carcinoma
Study
EGAS50000001325
-
Prevalence and association of microsatellite instability and Lynch syndrome Pan-Cancer and development of a personalized cancer risk prediction tool for Lynch syndrome carriers in India
Study
EGAS50000001449
-
A prospective multicenter study of plasma ctDNA versus archival tumor tissue to guide FGFR-targeted therapy in metastatic urothelial cancer - Targeted
Study
EGAS50000001450
-
Clinical data of liver cancer patients from EuCanImage - Use case 1 Synthetic
Study
EGAS50000001444
-
The INFORM Precision Medicine Study for High-Risk Pediatric Malignancies
Study
EGAS00001005112
-
Enzymatic Methyl-Seq Rectal Mucus
Study
EGAS50000001314
-
Molecular profiling of HGBCL-DH-BCL2 patients treated in the HOVON-152 trial
Study
EGAS50000001453
-
Homopolymer switches mediate adaptive mutability in mismatch repair-deficient colorectal cancer
Study
EGAS50000000218
-
INVADE cohort
Study
EGAS50000000219
-
ctDNA Quantification in Blood Plasma Using Deep Learning Based Fragle Tool
Study
EGAS50000000122
-
Heterogeneity and evolution of DNA mutation rates in microsatellite stable colorectal cancer. Higher mutation rates (MR) in metastatic tumours
Study
EGAS50000000147
-
Pancreatic Cancer NGS WGS data
Study
EGAS50000001078
-
Coding and regulatory somatic profiling of triple-negative breast cancer in Sub-Saharan African patients
Study
EGAS50000001013
-
KAT6A and KAT7 Histone Acetyltransferase Complexes Are Molecular Dependencies and Therapeutic Targets in NUP98-Rearranged Acute Myeloid Leukemia
Study
EGAS50000001075
-
Correlative Genomic Analysis of Durvalumab plus Pazopanib Combination in Patients with Advanced Soft Tissue Sarcomas
Study
EGAS50000000082
-
Integrated Single-Nucleus and Spatial Transcriptomics Elucidate Heterogeneity and Hypoxia-Driven Organization of Supratentorial Ependymoma
Study
EGAS50000001318
-
ERBB2/HER2 alterations in ctDNA and metachronous tissues of patients with metastatic urothelial cancer - WGS
Study
EGAS50000001082
-
ERBB2/HER2 alterations in ctDNA and metachronous tissues of patients with metastatic urothelial cancer - Targeted
Study
EGAS50000001081
-
End motifs analysis of circulating DNA from the plasma of patients with stage II-III breast cancer (n=50), stage I-III non-small cell lung cancer (n=56), metastatic colorectal cancer (mCRC) (n=15) and healthy individuals (n=37)..
Study
EGAS50000001319
-
TONIC-Trial-cfDNA-Project
Study
EGAS50000001308
-
Gene expression analysis of clear cell renal cell carcinoma
Study
EGAS50000001324
-
3D chromatin analysis of clear cell renal cell carcinoma using micro-C
Study
EGAS50000001323
-
DEPArray-based sorting of pure carcinoma and stromal populations from formalin-fixed paraffin-embedded (FFPE) tissues followed by targeted sequencing
Study
EGAS50000001327